165 related articles for article (PubMed ID: 9933091)
1. Transforming growth factor-beta isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes [corrected].
Pasch MC; Bos JD; Daha MR; Asghar SS
Eur J Immunol; 1999 Jan; 29(1):100-8. PubMed ID: 9933091
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-beta and TNF-alpha.
Cocuzzi ET; Bardenstein DS; Stavitsky A; Sundarraj N; Medof ME
Curr Eye Res; 2001 Aug; 23(2):86-92. PubMed ID: 11840345
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
4. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line.
Bjørge L; Jensen TS; Matre R
Cancer Immunol Immunother; 1996 Mar; 42(3):185-92. PubMed ID: 8640847
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
8. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4195-202. PubMed ID: 11095615
[TBL] [Abstract][Full Text] [Related]
9. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.
Marchbank KJ; Morgan BP; van den Berg CW
Immunology; 1995 May; 85(1):146-52. PubMed ID: 7543447
[TBL] [Abstract][Full Text] [Related]
11. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues.
Bardenstein DS; Cheyer C; Okada N; Morgan BP; Medof ME
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):519-24. PubMed ID: 9950613
[TBL] [Abstract][Full Text] [Related]
12. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
Juhl H; Helmig F; Baltzer K; Kalthoff H; Henne-Bruns D; Kremer B
J Surg Oncol; 1997 Mar; 64(3):222-30. PubMed ID: 9121154
[TBL] [Abstract][Full Text] [Related]
13. Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
Blok VT; Gelderman KA; Tijsma OH; Daha MR; Gorter A
Scand J Immunol; 2003 Jun; 57(6):591-9. PubMed ID: 12791098
[TBL] [Abstract][Full Text] [Related]
14. Complement regulatory proteins on the sperm surface: relevance to sperm motility.
Jiang H; Pillai S
Am J Reprod Immunol; 1998 Apr; 39(4):243-8. PubMed ID: 9553648
[TBL] [Abstract][Full Text] [Related]
15. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
[TBL] [Abstract][Full Text] [Related]
16. Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells.
van den Berg CW; Rix C; Hanna SM; Perez de la Lastra JM; Morgan BP
Transplantation; 2000 Aug; 70(4):667-73. PubMed ID: 10972227
[TBL] [Abstract][Full Text] [Related]
17. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues.
Thorsteinsson L; O'Dowd GM; Harrington PM; Johnson PM
APMIS; 1998 Sep; 106(9):869-78. PubMed ID: 9808413
[TBL] [Abstract][Full Text] [Related]
18. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
19. Expression of decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 in the human astroglioma cell line, D54-MG, and primary rat astrocytes.
Yang C; Jones JL; Barnum SR
J Neuroimmunol; 1993 Sep; 47(2):123-32. PubMed ID: 7690370
[TBL] [Abstract][Full Text] [Related]
20. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins.
Gasque P; Thomas A; Fontaine M; Morgan BP
J Neuroimmunol; 1996 May; 66(1-2):29-40. PubMed ID: 8964911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
